Owc Pharmaceutical Research Corp. (OTCMKTS:OWCP) Files An 8-K Other Events

Owc Pharmaceutical Research Corp. (OTCMKTS:OWCP) Files An 8-K Other Events
Item 8.01 Other Events.

Story continues below

On April 15, 2019, OWC Pharmaceutical Research Corp. (the Company) announced that it is canceling its special meeting of stockholders scheduled for 10:00 a.m., New York City Time, on April 18, 2019 (the Special Meeting) due to the lack of a sufficient number of votes in favor of Proposal 1 to be voted on at the Special Meeting.

About Owc Pharmaceutical Research Corp. (OTCMKTS:OWCP)

OWC Pharmaceutical Research Corp. is a medical cannabis research and development company. The Company is engaged in the research and development of cannabis-based medical products (the Product Prospects) for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications. The Company also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. As of September 30, 2016, the Company was engaged in two business activities: work with GUMI to commercialize and market the Company’s Electromagnetic Percussion Device (the Device), and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and/or diseases, such as multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD) migraines and a delivery system.

An ad to help with our costs